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Single nucleotide polymorphisms may be
useful as short−term predictors after
coronary artery by−pass grafting surgery:
the role of FGB g.4884C>T polymorphism
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We read with great interest the paper by Rywik et al. [1]
on the application and utility of complex polymorphism ana-
lysis in the assessment and prognosis after percutaneous co-
ronary intervention.
The authors observed that despite non-significant diffe-
rences in the gene variants distribution between patients and
controls, only E-selectine gene variants (SELE Ser128Arg) co-
uld be useful for patient stratification.
The previously reported gene variant SELE S128R is
a synonym for S149R (rs5361), a single nucleotide polymor-
phism (SNP) based on NCBI Reference Sequence, Accession
No: NM_000450.2. In the literature, both names are used.
However, according to the standard system for naming human
genes, we recommend using ESELE c.445A>C notation [2].
This common SNP of the E-selectin gene is a missense
exchange of A to C nucleotides, resulting in the substitution
of arginine (R) for serine (S) at position 149 (S149R) within
the epidermal growth factor-like domain of the mature pro-
tein [3]. This arginine substitution causes the loss of E-selectin
protein requirement for alpha 1-3-linked fucose to specific
ligand binding. Additionally, the 149R phenotype alters
E-selectin binding to heparin or sulfatide [4]. Clinical trials
have revealed that the 149R allele is associated with the early
onset of severe coronary artery disease (CAD) in subjects un-
der 50 years of age, the presence of coronary artery calcifica-
tion, and the increased risk of restenosis after percutaneous
transluminal angioplasty in patients with peripheral artery
disease [5–7].
In our study which was recently published the endothe-
lium-leukocyte interaction is enhanced by genetic modifica-
tion and results in the elevation of coagulation factors and
platelet mediators (b-thromboglobulin) [8]. This enhanced en-
dothelial activation has a significant influence, not only on
thrombotic complications in the immediate postoperative
period (i.e. myocardial infarction, stroke and fatal pulmonary
embolism), but also may regulate the long-term patient out-
come [1]. In our study, we assumed that the relative risk (RR)
of postoperative adverse events in the 149R allele carriers was
2.03 with a 95% confidence interval (95% CI 1.05–3.03), and
that the presence of common pro-thrombotic SNPs (FV Leiden
G1691A and prothrombin 20210A) did not increase the risk of
adverse events (p < 0.18) [8].
Moreover, we observed that in 140 patients with angio-
graphically proven two- or three-vessel CAD (mean age 65 ±
± 7.9 years), qualified to elective coronary artery bypass gra-
fting surgery and treated with low-dose aspirin (92% of them
on a dose of 75–150 mg daily), the common a-fibrinogen
p.Thr312Ala polymorphism (FGA c.991A>G, rs6050) influ-
enced thrombin generation. Thrombin generation analysis was
determined in platelet-poor plasma using a calibrated auto-
mated thrombogram (Thrombinoscope BV, Maastricht, The
Netherlands). Each measurement comprised analysis of the
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thrombin generation and calibrator in the presence of tissue
factor and phospholipids (final concentration: 5 pM and
4 mM, respectively) [9].
We observed that carriers of the Ala312 allele had a lower
thrombin peak (305.6 ± 79 nM) than non-carriers (350.3 ±
± 94 nM, p = 0.002). Lag time for Ala312 carriers and non-
-carriers was similar (1.67 ± 0.56 min vs 1.60 ± 0.63 min,
p = 0.4, respectively). The area under the curve did not differ
between Ala312 carriers (1945 ± 1974 nM × min) vs non-
-carriers (1,827 ± 522 nM × min, p = 0.8). In the group of
carriers, lower fibrinogen concentration was observed (4.0 ±
± 1.14 g/L) vs non-carriers (4.4 ± 1.13 g/L, p = 0.04).
In conclusion, the Ala312 polymorphism affects fibrino-
gen level and determines thrombin generation in patients with
severe CAD on low-dose aspirin, and this effect may be rela-
ted to fibrinogen concentration. Nevertheless, we cannot pro-
pose the mechanism of such a relationship. The FGA gene is
probably located in a cluster with other genes and may affect
not only fibrinogen gene expression but also other proteins
in a similar manner in which FGB g.4884C>T (-C148T,
rs1800787) influences C-reactive protein or interleukin-6 at
transcriptional level [10].
There is evidence as to the role of some genetic variants
and their implication in the prognosis of patients with CAD
undergoing revascularisation treatment. However, we should
be aware of the baseline characteristics of patients, e.g.
accompanying diseases such as diabetes, hypertension or in-
flammatory diseases, as well as their stages. On the basis of
these findings, we suggest that revealing SNPs, especially in
diabetic patients, may be a useful predictor of adverse events
caused by different interventional procedures.
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